nodes	percent_of_prediction	percent_of_DWPC	metapath
Orphenadrine—migraine—Prednisone—multiple sclerosis	0.655	1	CpDpCtD
Orphenadrine—CYP2E1—Fingolimod—multiple sclerosis	0.0675	0.314	CbGbCtD
Orphenadrine—CYP2E1—Mitoxantrone—multiple sclerosis	0.0317	0.147	CbGbCtD
Orphenadrine—CYP3A4—Fingolimod—multiple sclerosis	0.0205	0.0951	CbGbCtD
Orphenadrine—CYP2E1—Dexamethasone—multiple sclerosis	0.0165	0.0765	CbGbCtD
Orphenadrine—CYP2B6—Dexamethasone—multiple sclerosis	0.0162	0.0754	CbGbCtD
Orphenadrine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0132	0.0613	CbGbCtD
Orphenadrine—CYP3A4—Triamcinolone—multiple sclerosis	0.00999	0.0464	CbGbCtD
Orphenadrine—CYP3A4—Mitoxantrone—multiple sclerosis	0.00962	0.0447	CbGbCtD
Orphenadrine—CYP3A4—Betamethasone—multiple sclerosis	0.00857	0.0398	CbGbCtD
Orphenadrine—CYP3A4—Prednisolone—multiple sclerosis	0.00846	0.0393	CbGbCtD
Orphenadrine—CYP3A4—Prednisone—multiple sclerosis	0.00799	0.0371	CbGbCtD
Orphenadrine—CYP3A4—Dexamethasone—multiple sclerosis	0.00499	0.0232	CbGbCtD
Orphenadrine—SCN10A—peripheral nervous system—multiple sclerosis	0.00338	0.066	CbGeAlD
Orphenadrine—SCN10A—nerve—multiple sclerosis	0.00263	0.0515	CbGeAlD
Orphenadrine—GRIN2D—brainstem—multiple sclerosis	0.00213	0.0416	CbGeAlD
Orphenadrine—GRIN1—brainstem—multiple sclerosis	0.0019	0.037	CbGeAlD
Orphenadrine—SLC6A2—nerve—multiple sclerosis	0.00164	0.032	CbGeAlD
Orphenadrine—GRIN2D—medulla oblongata—multiple sclerosis	0.00148	0.029	CbGeAlD
Orphenadrine—GRIN2D—spinal cord—multiple sclerosis	0.00132	0.0258	CbGeAlD
Orphenadrine—SCN1A—brainstem—multiple sclerosis	0.00128	0.025	CbGeAlD
Orphenadrine—GRIN1—midbrain—multiple sclerosis	0.00121	0.0236	CbGeAlD
Orphenadrine—GRIN1—spinal cord—multiple sclerosis	0.00118	0.023	CbGeAlD
Orphenadrine—GRIN2D—nervous system—multiple sclerosis	0.00111	0.0218	CbGeAlD
Orphenadrine—GRIN2D—central nervous system—multiple sclerosis	0.00107	0.021	CbGeAlD
Orphenadrine—GRIN2D—cerebellum—multiple sclerosis	0.00105	0.0205	CbGeAlD
Orphenadrine—GRIN3A—nervous system—multiple sclerosis	0.00105	0.0205	CbGeAlD
Orphenadrine—GRIN3A—central nervous system—multiple sclerosis	0.00101	0.0197	CbGeAlD
Orphenadrine—GRIN1—nervous system—multiple sclerosis	0.000993	0.0194	CbGeAlD
Orphenadrine—GRIN1—central nervous system—multiple sclerosis	0.000956	0.0187	CbGeAlD
Orphenadrine—SCN9A—midbrain—multiple sclerosis	0.000946	0.0185	CbGeAlD
Orphenadrine—GRIN1—cerebellum—multiple sclerosis	0.000934	0.0183	CbGeAlD
Orphenadrine—Gastric irritation—Prednisone—multiple sclerosis	0.000925	0.0362	CcSEcCtD
Orphenadrine—SCN9A—spinal cord—multiple sclerosis	0.000923	0.018	CbGeAlD
Orphenadrine—SCN1A—medulla oblongata—multiple sclerosis	0.000891	0.0174	CbGeAlD
Orphenadrine—Aplastic anaemia—Cladribine—multiple sclerosis	0.00086	0.0336	CcSEcCtD
Orphenadrine—GRIN2D—brain—multiple sclerosis	0.000852	0.0166	CbGeAlD
Orphenadrine—SCN1A—midbrain—multiple sclerosis	0.000814	0.0159	CbGeAlD
Orphenadrine—GRIN3A—brain—multiple sclerosis	0.000801	0.0156	CbGeAlD
Orphenadrine—SCN1A—spinal cord—multiple sclerosis	0.000794	0.0155	CbGeAlD
Orphenadrine—GRIN1—brain—multiple sclerosis	0.000759	0.0148	CbGeAlD
Orphenadrine—SLC6A2—brainstem—multiple sclerosis	0.000703	0.0137	CbGeAlD
Orphenadrine—SCN10A—spinal cord—multiple sclerosis	0.000703	0.0137	CbGeAlD
Orphenadrine—Aplastic anaemia—Azathioprine—multiple sclerosis	0.000699	0.0273	CcSEcCtD
Orphenadrine—SCN4A—nervous system—multiple sclerosis	0.000694	0.0136	CbGeAlD
Orphenadrine—Epigastric discomfort—Prednisone—multiple sclerosis	0.000682	0.0267	CcSEcCtD
Orphenadrine—SCN1A—nervous system—multiple sclerosis	0.000669	0.0131	CbGeAlD
Orphenadrine—SCN4A—central nervous system—multiple sclerosis	0.000668	0.0131	CbGeAlD
Orphenadrine—Vision blurred—Fingolimod—multiple sclerosis	0.000665	0.026	CcSEcCtD
Orphenadrine—SCN1A—central nervous system—multiple sclerosis	0.000644	0.0126	CbGeAlD
Orphenadrine—SCN1A—cerebellum—multiple sclerosis	0.00063	0.0123	CbGeAlD
Orphenadrine—Palpitations—Fingolimod—multiple sclerosis	0.000624	0.0244	CcSEcCtD
Orphenadrine—Mydriasis—Prednisolone—multiple sclerosis	0.000619	0.0242	CcSEcCtD
Orphenadrine—SCN9A—brain—multiple sclerosis	0.000595	0.0116	CbGeAlD
Orphenadrine—SCN10A—nervous system—multiple sclerosis	0.000592	0.0116	CbGeAlD
Orphenadrine—SCN10A—central nervous system—multiple sclerosis	0.00057	0.0111	CbGeAlD
Orphenadrine—Skin disorder—Fingolimod—multiple sclerosis	0.00056	0.0219	CcSEcCtD
Orphenadrine—SCN5A—nervous system—multiple sclerosis	0.000538	0.0105	CbGeAlD
Orphenadrine—SCN4A—brain—multiple sclerosis	0.00053	0.0104	CbGeAlD
Orphenadrine—SCN5A—central nervous system—multiple sclerosis	0.000518	0.0101	CbGeAlD
Orphenadrine—SCN1A—brain—multiple sclerosis	0.000511	0.01	CbGeAlD
Orphenadrine—SLC6A2—medulla oblongata—multiple sclerosis	0.000491	0.00959	CbGeAlD
Orphenadrine—CHRM2—nervous system—multiple sclerosis	0.000458	0.00895	CbGeAlD
Orphenadrine—SCN10A—brain—multiple sclerosis	0.000453	0.00885	CbGeAlD
Orphenadrine—CHRM2—central nervous system—multiple sclerosis	0.000441	0.00862	CbGeAlD
Orphenadrine—KCNH2—medulla oblongata—multiple sclerosis	0.00044	0.00861	CbGeAlD
Orphenadrine—Asthenia—Fingolimod—multiple sclerosis	0.000413	0.0162	CcSEcCtD
Orphenadrine—SCN5A—brain—multiple sclerosis	0.000411	0.00804	CbGeAlD
Orphenadrine—Pruritus—Fingolimod—multiple sclerosis	0.000408	0.0159	CcSEcCtD
Orphenadrine—Cyclopentolate—BCHE—multiple sclerosis	0.000405	0.365	CrCbGaD
Orphenadrine—KCNH2—midbrain—multiple sclerosis	0.000403	0.00787	CbGeAlD
Orphenadrine—KCNH2—spinal cord—multiple sclerosis	0.000393	0.00768	CbGeAlD
Orphenadrine—Dizziness—Fingolimod—multiple sclerosis	0.000381	0.0149	CcSEcCtD
Orphenadrine—SLC6A2—nervous system—multiple sclerosis	0.000369	0.0072	CbGeAlD
Orphenadrine—Headache—Fingolimod—multiple sclerosis	0.000361	0.0141	CcSEcCtD
Orphenadrine—SLC6A2—central nervous system—multiple sclerosis	0.000355	0.00694	CbGeAlD
Orphenadrine—CHRM2—brain—multiple sclerosis	0.00035	0.00684	CbGeAlD
Orphenadrine—CYP2E1—medulla oblongata—multiple sclerosis	0.000339	0.00663	CbGeAlD
Orphenadrine—Drowsiness—Mitoxantrone—multiple sclerosis	0.000337	0.0132	CcSEcCtD
Orphenadrine—KCNH2—nervous system—multiple sclerosis	0.000331	0.00647	CbGeAlD
Orphenadrine—Confusional state—Cladribine—multiple sclerosis	0.000329	0.0129	CcSEcCtD
Orphenadrine—Tachycardia—Cladribine—multiple sclerosis	0.000319	0.0125	CcSEcCtD
Orphenadrine—KCNH2—central nervous system—multiple sclerosis	0.000319	0.00623	CbGeAlD
Orphenadrine—Skin disorder—Cladribine—multiple sclerosis	0.000317	0.0124	CcSEcCtD
Orphenadrine—KCNH2—cerebellum—multiple sclerosis	0.000311	0.00609	CbGeAlD
Orphenadrine—CYP2E1—spinal cord—multiple sclerosis	0.000302	0.00591	CbGeAlD
Orphenadrine—Somnolence—Cladribine—multiple sclerosis	0.00029	0.0114	CcSEcCtD
Orphenadrine—SLC6A2—brain—multiple sclerosis	0.000282	0.00551	CbGeAlD
Orphenadrine—Aplastic anaemia—Methotrexate—multiple sclerosis	0.000282	0.011	CcSEcCtD
Orphenadrine—Constipation—Cladribine—multiple sclerosis	0.000279	0.0109	CcSEcCtD
Orphenadrine—CYP2B6—nervous system—multiple sclerosis	0.000272	0.00531	CbGeAlD
Orphenadrine—Feeling abnormal—Cladribine—multiple sclerosis	0.000269	0.0105	CcSEcCtD
Orphenadrine—HRH1—nervous system—multiple sclerosis	0.000265	0.00518	CbGeAlD
Orphenadrine—CYP2B6—central nervous system—multiple sclerosis	0.000261	0.00511	CbGeAlD
Orphenadrine—Urticaria—Cladribine—multiple sclerosis	0.00026	0.0101	CcSEcCtD
Orphenadrine—Skin disorder—Azathioprine—multiple sclerosis	0.000258	0.0101	CcSEcCtD
Orphenadrine—HRH1—central nervous system—multiple sclerosis	0.000255	0.00499	CbGeAlD
Orphenadrine—CYP2E1—nervous system—multiple sclerosis	0.000255	0.00498	CbGeAlD
Orphenadrine—KCNH2—brain—multiple sclerosis	0.000253	0.00494	CbGeAlD
Orphenadrine—Vision blurred—Mitoxantrone—multiple sclerosis	0.000248	0.0097	CcSEcCtD
Orphenadrine—Ethopropazine—BCHE—multiple sclerosis	0.000246	0.222	CrCbGaD
Orphenadrine—CYP2E1—central nervous system—multiple sclerosis	0.000245	0.0048	CbGeAlD
Orphenadrine—Hypersensitivity—Cladribine—multiple sclerosis	0.000241	0.00941	CcSEcCtD
Orphenadrine—CYP2E1—cerebellum—multiple sclerosis	0.00024	0.00469	CbGeAlD
Orphenadrine—Asthenia—Cladribine—multiple sclerosis	0.000234	0.00916	CcSEcCtD
Orphenadrine—Pruritus—Cladribine—multiple sclerosis	0.000231	0.00904	CcSEcCtD
Orphenadrine—Hallucination—Methylprednisolone—multiple sclerosis	0.000226	0.00885	CcSEcCtD
Orphenadrine—Feeling abnormal—Azathioprine—multiple sclerosis	0.000219	0.00856	CcSEcCtD
Orphenadrine—Confusional state—Mitoxantrone—multiple sclerosis	0.000216	0.00847	CcSEcCtD
Orphenadrine—Dizziness—Cladribine—multiple sclerosis	0.000216	0.00845	CcSEcCtD
Orphenadrine—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000215	0.0084	CcSEcCtD
Orphenadrine—Tachycardia—Mitoxantrone—multiple sclerosis	0.00021	0.00819	CcSEcCtD
Orphenadrine—Skin disorder—Mitoxantrone—multiple sclerosis	0.000209	0.00816	CcSEcCtD
Orphenadrine—Vomiting—Cladribine—multiple sclerosis	0.000208	0.00812	CcSEcCtD
Orphenadrine—CYP2B6—brain—multiple sclerosis	0.000208	0.00406	CbGeAlD
Orphenadrine—Hallucination—Betamethasone—multiple sclerosis	0.000206	0.00805	CcSEcCtD
Orphenadrine—Hallucination—Dexamethasone—multiple sclerosis	0.000206	0.00805	CcSEcCtD
Orphenadrine—CYP3A4—nervous system—multiple sclerosis	0.000205	0.00401	CbGeAlD
Orphenadrine—Headache—Cladribine—multiple sclerosis	0.000205	0.008	CcSEcCtD
Orphenadrine—Vision blurred—Prednisolone—multiple sclerosis	0.000203	0.00795	CcSEcCtD
Orphenadrine—HRH1—brain—multiple sclerosis	0.000203	0.00396	CbGeAlD
Orphenadrine—CYP3A4—central nervous system—multiple sclerosis	0.000197	0.00386	CbGeAlD
Orphenadrine—Hypersensitivity—Azathioprine—multiple sclerosis	0.000196	0.00765	CcSEcCtD
Orphenadrine—CYP2E1—brain—multiple sclerosis	0.000195	0.00381	CbGeAlD
Orphenadrine—Nausea—Cladribine—multiple sclerosis	0.000194	0.00759	CcSEcCtD
Orphenadrine—Somnolence—Mitoxantrone—multiple sclerosis	0.000191	0.00746	CcSEcCtD
Orphenadrine—Constipation—Mitoxantrone—multiple sclerosis	0.000184	0.00718	CcSEcCtD
Orphenadrine—Hallucination—Prednisone—multiple sclerosis	0.000179	0.00701	CcSEcCtD
Orphenadrine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000177	0.00692	CcSEcCtD
Orphenadrine—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000176	0.00689	CcSEcCtD
Orphenadrine—Dizziness—Azathioprine—multiple sclerosis	0.000176	0.00687	CcSEcCtD
Orphenadrine—Tachycardia—Prednisolone—multiple sclerosis	0.000172	0.00672	CcSEcCtD
Orphenadrine—Urticaria—Mitoxantrone—multiple sclerosis	0.000171	0.00667	CcSEcCtD
Orphenadrine—Vomiting—Azathioprine—multiple sclerosis	0.000169	0.0066	CcSEcCtD
Orphenadrine—Drowsiness—Methotrexate—multiple sclerosis	0.000168	0.00656	CcSEcCtD
Orphenadrine—Headache—Azathioprine—multiple sclerosis	0.000166	0.00651	CcSEcCtD
Orphenadrine—Confusional state—Methylprednisolone—multiple sclerosis	0.000163	0.00637	CcSEcCtD
Orphenadrine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000162	0.00633	CcSEcCtD
Orphenadrine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000162	0.00632	CcSEcCtD
Orphenadrine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000158	0.00619	CcSEcCtD
Orphenadrine—Tachycardia—Triamcinolone—multiple sclerosis	0.000158	0.00618	CcSEcCtD
Orphenadrine—Nausea—Azathioprine—multiple sclerosis	0.000158	0.00617	CcSEcCtD
Orphenadrine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000158	0.00617	CcSEcCtD
Orphenadrine—Skin disorder—Methylprednisolone—multiple sclerosis	0.000157	0.00614	CcSEcCtD
Orphenadrine—Asthenia—Mitoxantrone—multiple sclerosis	0.000154	0.00602	CcSEcCtD
Orphenadrine—Vision blurred—Prednisone—multiple sclerosis	0.000148	0.00578	CcSEcCtD
Orphenadrine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000147	0.00575	CcSEcCtD
Orphenadrine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000147	0.00575	CcSEcCtD
Orphenadrine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000145	0.00568	CcSEcCtD
Orphenadrine—Agitation—Prednisone—multiple sclerosis	0.000144	0.00564	CcSEcCtD
Orphenadrine—Tachycardia—Dexamethasone—multiple sclerosis	0.000143	0.00561	CcSEcCtD
Orphenadrine—Tachycardia—Betamethasone—multiple sclerosis	0.000143	0.00561	CcSEcCtD
Orphenadrine—Urticaria—Prednisolone—multiple sclerosis	0.00014	0.00547	CcSEcCtD
Orphenadrine—Vomiting—Mitoxantrone—multiple sclerosis	0.000137	0.00534	CcSEcCtD
Orphenadrine—Headache—Mitoxantrone—multiple sclerosis	0.000135	0.00526	CcSEcCtD
Orphenadrine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000133	0.00522	CcSEcCtD
Orphenadrine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000133	0.00521	CcSEcCtD
Orphenadrine—Hypersensitivity—Prednisolone—multiple sclerosis	0.00013	0.00508	CcSEcCtD
Orphenadrine—Urticaria—Triamcinolone—multiple sclerosis	0.000129	0.00503	CcSEcCtD
Orphenadrine—Urticaria—Methylprednisolone—multiple sclerosis	0.000128	0.00502	CcSEcCtD
Orphenadrine—Anaphylactic shock—Prednisone—multiple sclerosis	0.000128	0.00501	CcSEcCtD
Orphenadrine—Nausea—Mitoxantrone—multiple sclerosis	0.000128	0.00499	CcSEcCtD
Orphenadrine—Tachycardia—Prednisone—multiple sclerosis	0.000125	0.00489	CcSEcCtD
Orphenadrine—Skin disorder—Prednisone—multiple sclerosis	0.000124	0.00486	CcSEcCtD
Orphenadrine—Vision blurred—Methotrexate—multiple sclerosis	0.000124	0.00483	CcSEcCtD
Orphenadrine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000121	0.00474	CcSEcCtD
Orphenadrine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000121	0.00474	CcSEcCtD
Orphenadrine—Fenoprofen—ALB—multiple sclerosis	0.000121	0.109	CrCbGaD
Orphenadrine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000119	0.00467	CcSEcCtD
Orphenadrine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000119	0.00466	CcSEcCtD
Orphenadrine—Urticaria—Betamethasone—multiple sclerosis	0.000117	0.00457	CcSEcCtD
Orphenadrine—Urticaria—Dexamethasone—multiple sclerosis	0.000117	0.00457	CcSEcCtD
Orphenadrine—Dizziness—Prednisolone—multiple sclerosis	0.000116	0.00456	CcSEcCtD
Orphenadrine—Asthenia—Triamcinolone—multiple sclerosis	0.000116	0.00454	CcSEcCtD
Orphenadrine—Asthenia—Methylprednisolone—multiple sclerosis	0.000116	0.00453	CcSEcCtD
Orphenadrine—Pruritus—Triamcinolone—multiple sclerosis	0.000115	0.00448	CcSEcCtD
Orphenadrine—Pruritus—Methylprednisolone—multiple sclerosis	0.000114	0.00447	CcSEcCtD
Orphenadrine—Headache—Prednisolone—multiple sclerosis	0.00011	0.00432	CcSEcCtD
Orphenadrine—Constipation—Prednisone—multiple sclerosis	0.000109	0.00428	CcSEcCtD
Orphenadrine—Confusional state—Methotrexate—multiple sclerosis	0.000108	0.00422	CcSEcCtD
Orphenadrine—Dizziness—Triamcinolone—multiple sclerosis	0.000107	0.00419	CcSEcCtD
Orphenadrine—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000107	0.00418	CcSEcCtD
Orphenadrine—Dizziness—Methylprednisolone—multiple sclerosis	0.000107	0.00418	CcSEcCtD
Orphenadrine—Feeling abnormal—Prednisone—multiple sclerosis	0.000105	0.00412	CcSEcCtD
Orphenadrine—Asthenia—Betamethasone—multiple sclerosis	0.000105	0.00412	CcSEcCtD
Orphenadrine—Asthenia—Dexamethasone—multiple sclerosis	0.000105	0.00412	CcSEcCtD
Orphenadrine—Nausea—Prednisolone—multiple sclerosis	0.000105	0.00409	CcSEcCtD
Orphenadrine—Pruritus—Dexamethasone—multiple sclerosis	0.000104	0.00407	CcSEcCtD
Orphenadrine—Pruritus—Betamethasone—multiple sclerosis	0.000104	0.00407	CcSEcCtD
Orphenadrine—Phenprocoumon—ALB—multiple sclerosis	0.000104	0.0938	CrCbGaD
Orphenadrine—Skin disorder—Methotrexate—multiple sclerosis	0.000104	0.00406	CcSEcCtD
Orphenadrine—Vomiting—Triamcinolone—multiple sclerosis	0.000103	0.00403	CcSEcCtD
Orphenadrine—Vomiting—Methylprednisolone—multiple sclerosis	0.000103	0.00402	CcSEcCtD
Orphenadrine—Urticaria—Prednisone—multiple sclerosis	0.000102	0.00398	CcSEcCtD
Orphenadrine—Headache—Triamcinolone—multiple sclerosis	0.000101	0.00397	CcSEcCtD
Orphenadrine—Headache—Methylprednisolone—multiple sclerosis	0.000101	0.00396	CcSEcCtD
Orphenadrine—Fluoxetine—ALB—multiple sclerosis	0.000101	0.0913	CrCbGaD
Orphenadrine—Dizziness—Dexamethasone—multiple sclerosis	9.72e-05	0.0038	CcSEcCtD
Orphenadrine—Dizziness—Betamethasone—multiple sclerosis	9.72e-05	0.0038	CcSEcCtD
Orphenadrine—Nausea—Triamcinolone—multiple sclerosis	9.62e-05	0.00376	CcSEcCtD
Orphenadrine—Nausea—Methylprednisolone—multiple sclerosis	9.6e-05	0.00375	CcSEcCtD
Orphenadrine—Somnolence—Methotrexate—multiple sclerosis	9.51e-05	0.00372	CcSEcCtD
Orphenadrine—Hypersensitivity—Prednisone—multiple sclerosis	9.43e-05	0.00369	CcSEcCtD
Orphenadrine—Vomiting—Dexamethasone—multiple sclerosis	9.35e-05	0.00365	CcSEcCtD
Orphenadrine—Vomiting—Betamethasone—multiple sclerosis	9.35e-05	0.00365	CcSEcCtD
Orphenadrine—Warfarin—ALB—multiple sclerosis	9.22e-05	0.0832	CrCbGaD
Orphenadrine—Headache—Dexamethasone—multiple sclerosis	9.21e-05	0.0036	CcSEcCtD
Orphenadrine—Headache—Betamethasone—multiple sclerosis	9.21e-05	0.0036	CcSEcCtD
Orphenadrine—Asthenia—Prednisone—multiple sclerosis	9.18e-05	0.00359	CcSEcCtD
Orphenadrine—Pruritus—Prednisone—multiple sclerosis	9.06e-05	0.00354	CcSEcCtD
Orphenadrine—Feeling abnormal—Methotrexate—multiple sclerosis	8.82e-05	0.00345	CcSEcCtD
Orphenadrine—Nausea—Dexamethasone—multiple sclerosis	8.73e-05	0.00341	CcSEcCtD
Orphenadrine—Nausea—Betamethasone—multiple sclerosis	8.73e-05	0.00341	CcSEcCtD
Orphenadrine—Urticaria—Methotrexate—multiple sclerosis	8.5e-05	0.00332	CcSEcCtD
Orphenadrine—Dizziness—Prednisone—multiple sclerosis	8.46e-05	0.00331	CcSEcCtD
Orphenadrine—Vomiting—Prednisone—multiple sclerosis	8.14e-05	0.00318	CcSEcCtD
Orphenadrine—Headache—Prednisone—multiple sclerosis	8.02e-05	0.00314	CcSEcCtD
Orphenadrine—Hypersensitivity—Methotrexate—multiple sclerosis	7.88e-05	0.00308	CcSEcCtD
Orphenadrine—Asthenia—Methotrexate—multiple sclerosis	7.68e-05	0.003	CcSEcCtD
Orphenadrine—Nausea—Prednisone—multiple sclerosis	7.6e-05	0.00297	CcSEcCtD
Orphenadrine—Pruritus—Methotrexate—multiple sclerosis	7.57e-05	0.00296	CcSEcCtD
Orphenadrine—Dizziness—Methotrexate—multiple sclerosis	7.07e-05	0.00277	CcSEcCtD
Orphenadrine—Vomiting—Methotrexate—multiple sclerosis	6.8e-05	0.00266	CcSEcCtD
Orphenadrine—Headache—Methotrexate—multiple sclerosis	6.7e-05	0.00262	CcSEcCtD
Orphenadrine—Nausea—Methotrexate—multiple sclerosis	6.35e-05	0.00248	CcSEcCtD
Orphenadrine—Amitriptyline—ALB—multiple sclerosis	3.94e-05	0.0356	CrCbGaD
Orphenadrine—HRH1—GPCR ligand binding—CCR2—multiple sclerosis	3.31e-05	0.000636	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—MMP9—multiple sclerosis	3.31e-05	0.000635	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—RGS1—multiple sclerosis	3.29e-05	0.000633	CbGpPWpGaD
Orphenadrine—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	3.27e-05	0.000628	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—MAPK1—multiple sclerosis	3.27e-05	0.000628	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—MAPK1—multiple sclerosis	3.27e-05	0.000628	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—SRM—multiple sclerosis	3.26e-05	0.000626	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—CCR2—multiple sclerosis	3.26e-05	0.000626	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—MMP9—multiple sclerosis	3.25e-05	0.000626	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	3.22e-05	0.000618	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—SRM—multiple sclerosis	3.19e-05	0.000613	CbGpPWpGaD
Orphenadrine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.19e-05	0.000612	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—GPR65—multiple sclerosis	3.17e-05	0.00061	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—IL6—multiple sclerosis	3.17e-05	0.000609	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—GPR65—multiple sclerosis	3.12e-05	0.0006	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	3.11e-05	0.000597	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	3.07e-05	0.00059	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	3.06e-05	0.000588	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—CNR1—multiple sclerosis	3.05e-05	0.000587	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—RGS1—multiple sclerosis	3.04e-05	0.000584	CbGpPWpGaD
Orphenadrine—CYP2B6—Biological oxidations—POMC—multiple sclerosis	3.02e-05	0.00058	CbGpPWpGaD
Orphenadrine—GRIN1—Neuronal System—MAPK1—multiple sclerosis	3.01e-05	0.000579	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—CNR1—multiple sclerosis	3e-05	0.000577	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—TYK2—multiple sclerosis	3e-05	0.000576	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—MMP9—multiple sclerosis	2.99e-05	0.000575	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—RGS1—multiple sclerosis	2.99e-05	0.000575	CbGpPWpGaD
Orphenadrine—CYP2E1—Biological oxidations—POMC—multiple sclerosis	2.96e-05	0.000568	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—CXCL13—multiple sclerosis	2.9e-05	0.000558	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—CCR1—multiple sclerosis	2.9e-05	0.000558	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—STAT3—multiple sclerosis	2.89e-05	0.000556	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—MMP9—multiple sclerosis	2.88e-05	0.000554	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—MMP9—multiple sclerosis	2.88e-05	0.000554	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—GPR65—multiple sclerosis	2.88e-05	0.000554	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—CCR1—multiple sclerosis	2.85e-05	0.000549	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—CXCL13—multiple sclerosis	2.85e-05	0.000549	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—MMP9—multiple sclerosis	2.84e-05	0.000546	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—GPR65—multiple sclerosis	2.83e-05	0.000545	CbGpPWpGaD
Orphenadrine—SCN9A—Axon guidance—IL6—multiple sclerosis	2.83e-05	0.000544	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	2.8e-05	0.000538	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	2.79e-05	0.000536	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—LINGO1—multiple sclerosis	2.79e-05	0.000535	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	2.75e-05	0.000529	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—CXCL10—multiple sclerosis	2.75e-05	0.000528	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—LINGO1—multiple sclerosis	2.74e-05	0.000527	CbGpPWpGaD
Orphenadrine—CHRM2—G alpha (i) signalling events—POMC—multiple sclerosis	2.71e-05	0.00052	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—CXCL10—multiple sclerosis	2.7e-05	0.00052	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—TGFB1—multiple sclerosis	2.68e-05	0.000516	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—MAPK1—multiple sclerosis	2.67e-05	0.000514	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—STAT3—multiple sclerosis	2.66e-05	0.000511	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CXCL13—multiple sclerosis	2.63e-05	0.000506	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CCR1—multiple sclerosis	2.63e-05	0.000506	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—MAPK1—multiple sclerosis	2.63e-05	0.000506	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	2.63e-05	0.000505	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—IL6—multiple sclerosis	2.6e-05	0.0005	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CCR1—multiple sclerosis	2.59e-05	0.000498	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CXCL13—multiple sclerosis	2.59e-05	0.000498	CbGpPWpGaD
Orphenadrine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.58e-05	0.000496	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—TYK2—multiple sclerosis	2.57e-05	0.000495	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—STAT3—multiple sclerosis	2.56e-05	0.000493	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—STAT3—multiple sclerosis	2.56e-05	0.000493	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—IL6—multiple sclerosis	2.51e-05	0.000482	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—IL6—multiple sclerosis	2.51e-05	0.000482	CbGpPWpGaD
Orphenadrine—KCNH2—Neuronal System—MAPK1—multiple sclerosis	2.51e-05	0.000482	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—TNF—multiple sclerosis	2.5e-05	0.000481	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—TGFB1—multiple sclerosis	2.46e-05	0.000474	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—MAPK1—multiple sclerosis	2.42e-05	0.000465	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TAGAP—multiple sclerosis	2.42e-05	0.000464	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—TGFB1—multiple sclerosis	2.38e-05	0.000457	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—TGFB1—multiple sclerosis	2.38e-05	0.000457	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TAGAP—multiple sclerosis	2.38e-05	0.000457	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—CCL5—multiple sclerosis	2.37e-05	0.000455	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—MMP9—multiple sclerosis	2.36e-05	0.000453	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—MAPK1—multiple sclerosis	2.33e-05	0.000448	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—MAPK1—multiple sclerosis	2.33e-05	0.000448	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—CCL5—multiple sclerosis	2.33e-05	0.000448	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—TNF—multiple sclerosis	2.3e-05	0.000442	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—MAPK1—multiple sclerosis	2.3e-05	0.000441	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	2.3e-05	0.000441	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	2.3e-05	0.000441	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	2.25e-05	0.000432	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	2.25e-05	0.000432	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—TNF—multiple sclerosis	2.22e-05	0.000427	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—TNF—multiple sclerosis	2.22e-05	0.000427	CbGpPWpGaD
Orphenadrine—CHRM2—Regulation of Actin Cytoskeleton—MAPK1—multiple sclerosis	2.2e-05	0.000424	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	2.19e-05	0.000421	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	2.15e-05	0.000414	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	2.14e-05	0.000411	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—CCR5—multiple sclerosis	2.13e-05	0.00041	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—S1PR1—multiple sclerosis	2.11e-05	0.000406	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	2.11e-05	0.000405	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GPC5—multiple sclerosis	2.1e-05	0.000404	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—CCR5—multiple sclerosis	2.1e-05	0.000403	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—STAT3—multiple sclerosis	2.1e-05	0.000403	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—S1PR1—multiple sclerosis	2.08e-05	0.000399	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GPC5—multiple sclerosis	2.06e-05	0.000395	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—GPC5—multiple sclerosis	2.05e-05	0.000395	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—IL6—multiple sclerosis	2.05e-05	0.000395	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—MMP9—multiple sclerosis	2.03e-05	0.00039	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—TNF—multiple sclerosis	2.02e-05	0.000389	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—IL6—multiple sclerosis	2.02e-05	0.000388	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—GPC5—multiple sclerosis	2.02e-05	0.000388	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—PTGER4—multiple sclerosis	1.99e-05	0.000382	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—PTGER4—multiple sclerosis	1.96e-05	0.000376	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—TGFB1—multiple sclerosis	1.94e-05	0.000374	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—CXCR3—multiple sclerosis	1.92e-05	0.000369	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—MAPK1—multiple sclerosis	1.91e-05	0.000366	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—CXCR3—multiple sclerosis	1.89e-05	0.000363	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CCL3—multiple sclerosis	1.88e-05	0.000361	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—CCR2—multiple sclerosis	1.87e-05	0.000359	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—IL6—multiple sclerosis	1.86e-05	0.000357	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CCL3—multiple sclerosis	1.85e-05	0.000355	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—CCR2—multiple sclerosis	1.84e-05	0.000354	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—TNF—multiple sclerosis	1.82e-05	0.000349	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—PTGER4—multiple sclerosis	1.81e-05	0.000347	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—STAT3—multiple sclerosis	1.8e-05	0.000346	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—RGS1—multiple sclerosis	1.8e-05	0.000345	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—IL6—multiple sclerosis	1.79e-05	0.000344	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—IL6—multiple sclerosis	1.79e-05	0.000344	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—PTGER4—multiple sclerosis	1.78e-05	0.000342	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—RGS1—multiple sclerosis	1.77e-05	0.00034	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—IL6—multiple sclerosis	1.76e-05	0.000339	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CXCR3—multiple sclerosis	1.75e-05	0.000335	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—RRM1—multiple sclerosis	1.74e-05	0.000334	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—CNR1—multiple sclerosis	1.73e-05	0.000332	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CXCR3—multiple sclerosis	1.72e-05	0.00033	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—RRM1—multiple sclerosis	1.7e-05	0.000328	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—GPR65—multiple sclerosis	1.7e-05	0.000327	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CCR2—multiple sclerosis	1.7e-05	0.000326	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—CNR1—multiple sclerosis	1.7e-05	0.000326	CbGpPWpGaD
Orphenadrine—SLC6A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.68e-05	0.000324	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—GPR65—multiple sclerosis	1.67e-05	0.000322	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	1.67e-05	0.000321	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—TGFB1—multiple sclerosis	1.67e-05	0.000321	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CCR2—multiple sclerosis	1.67e-05	0.000321	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—POMC—multiple sclerosis	1.67e-05	0.00032	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—POMC—multiple sclerosis	1.64e-05	0.000315	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—MAPK1—multiple sclerosis	1.64e-05	0.000315	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	1.63e-05	0.000314	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—CCL2—multiple sclerosis	1.63e-05	0.000313	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—CCL2—multiple sclerosis	1.6e-05	0.000308	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CNR1—multiple sclerosis	1.57e-05	0.000301	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—TNF—multiple sclerosis	1.56e-05	0.0003	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CXCL13—multiple sclerosis	1.56e-05	0.000299	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CCR1—multiple sclerosis	1.56e-05	0.000299	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—CXCL10—multiple sclerosis	1.55e-05	0.000299	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CNR1—multiple sclerosis	1.54e-05	0.000296	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CXCL13—multiple sclerosis	1.53e-05	0.000294	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CCR1—multiple sclerosis	1.53e-05	0.000294	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—CXCL10—multiple sclerosis	1.53e-05	0.000294	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SRM—multiple sclerosis	1.48e-05	0.000285	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—IL6—multiple sclerosis	1.47e-05	0.000282	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CXCL10—multiple sclerosis	1.41e-05	0.000271	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CXCL10—multiple sclerosis	1.39e-05	0.000267	CbGpPWpGaD
Orphenadrine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.37e-05	0.000264	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—CCL5—multiple sclerosis	1.34e-05	0.000257	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—CCL5—multiple sclerosis	1.32e-05	0.000253	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	1.28e-05	0.000247	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—IL6—multiple sclerosis	1.26e-05	0.000242	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CCL5—multiple sclerosis	1.21e-05	0.000233	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—CCR5—multiple sclerosis	1.2e-05	0.000232	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CCL5—multiple sclerosis	1.19e-05	0.00023	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—IL2RA—multiple sclerosis	1.19e-05	0.000228	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—CCR5—multiple sclerosis	1.19e-05	0.000228	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—IL2RA—multiple sclerosis	1.17e-05	0.000225	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CCL3—multiple sclerosis	1.11e-05	0.000213	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CCR5—multiple sclerosis	1.09e-05	0.00021	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CCL3—multiple sclerosis	1.09e-05	0.00021	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—IL2RA—multiple sclerosis	1.08e-05	0.000207	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CCR5—multiple sclerosis	1.08e-05	0.000207	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PTGER4—multiple sclerosis	1.07e-05	0.000205	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—IL2RA—multiple sclerosis	1.06e-05	0.000204	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PGR—multiple sclerosis	1.05e-05	0.000202	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PTGER4—multiple sclerosis	1.05e-05	0.000202	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.04e-05	0.0002	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.04e-05	0.0002	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PGR—multiple sclerosis	1.03e-05	0.000199	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CXCR3—multiple sclerosis	1.03e-05	0.000198	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CD28—multiple sclerosis	1.02e-05	0.000196	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CXCR3—multiple sclerosis	1.01e-05	0.000195	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CD28—multiple sclerosis	1e-05	0.000193	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CCR2—multiple sclerosis	1e-05	0.000193	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—BCHE—multiple sclerosis	9.99e-06	0.000192	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CCR2—multiple sclerosis	9.87e-06	0.00019	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—BCHE—multiple sclerosis	9.79e-06	0.000188	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GPC5—multiple sclerosis	9.54e-06	0.000183	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—POMC—multiple sclerosis	9.42e-06	0.000181	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—POMC—multiple sclerosis	9.26e-06	0.000178	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CNR1—multiple sclerosis	9.26e-06	0.000178	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CNR1—multiple sclerosis	9.11e-06	0.000175	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—POMC—multiple sclerosis	8.55e-06	0.000164	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—POMC—multiple sclerosis	8.41e-06	0.000162	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CCL2—multiple sclerosis	8.37e-06	0.000161	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CXCL10—multiple sclerosis	8.33e-06	0.00016	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CCL2—multiple sclerosis	8.23e-06	0.000158	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CXCL10—multiple sclerosis	8.2e-06	0.000158	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—RRM1—multiple sclerosis	7.91e-06	0.000152	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—TYK2—multiple sclerosis	7.6e-06	0.000146	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—TYK2—multiple sclerosis	7.48e-06	0.000144	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CD86—multiple sclerosis	7.29e-06	0.00014	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CCL5—multiple sclerosis	7.17e-06	0.000138	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CD86—multiple sclerosis	7.17e-06	0.000138	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CCL5—multiple sclerosis	7.06e-06	0.000136	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—IL2—multiple sclerosis	6.96e-06	0.000134	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—IL2—multiple sclerosis	6.85e-06	0.000132	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—SPP1—multiple sclerosis	6.64e-06	0.000128	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—SPP1—multiple sclerosis	6.54e-06	0.000126	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CCR5—multiple sclerosis	6.46e-06	0.000124	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IL2RA—multiple sclerosis	6.37e-06	0.000122	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CCR5—multiple sclerosis	6.36e-06	0.000122	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—IL2—multiple sclerosis	6.32e-06	0.000122	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IL2RA—multiple sclerosis	6.27e-06	0.00012	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—IL2—multiple sclerosis	6.22e-06	0.00012	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—APOE—multiple sclerosis	6.01e-06	0.000116	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—APOE—multiple sclerosis	5.89e-06	0.000113	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—APOE—multiple sclerosis	5.88e-06	0.000113	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—APOE—multiple sclerosis	5.79e-06	0.000111	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CD80—multiple sclerosis	5.32e-06	0.000102	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CD80—multiple sclerosis	5.23e-06	0.000101	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—POMC—multiple sclerosis	5.16e-06	9.93e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—POMC—multiple sclerosis	5.06e-06	9.72e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—POMC—multiple sclerosis	5.05e-06	9.71e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—POMC—multiple sclerosis	4.97e-06	9.55e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CCL2—multiple sclerosis	4.94e-06	9.5e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CCL2—multiple sclerosis	4.86e-06	9.35e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—MAPK1—multiple sclerosis	4.84e-06	9.29e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—MAPK1—multiple sclerosis	4.76e-06	9.15e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ALB—multiple sclerosis	4.71e-06	9.05e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ALB—multiple sclerosis	4.61e-06	8.86e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—BCHE—multiple sclerosis	4.54e-06	8.73e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TYK2—multiple sclerosis	4.49e-06	8.63e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TYK2—multiple sclerosis	4.42e-06	8.49e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IL2—multiple sclerosis	3.73e-06	7.18e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—IL6—multiple sclerosis	3.72e-06	7.14e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IL2—multiple sclerosis	3.67e-06	7.06e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—IL6—multiple sclerosis	3.66e-06	7.03e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MMP9—multiple sclerosis	3.53e-06	6.79e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MMP9—multiple sclerosis	3.48e-06	6.68e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—STAT3—multiple sclerosis	3.14e-06	6.04e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—STAT3—multiple sclerosis	3.09e-06	5.94e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MYC—multiple sclerosis	2.92e-06	5.61e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TGFB1—multiple sclerosis	2.91e-06	5.6e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MYC—multiple sclerosis	2.87e-06	5.52e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TGFB1—multiple sclerosis	2.87e-06	5.51e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MAPK1—multiple sclerosis	2.86e-06	5.49e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MAPK1—multiple sclerosis	2.81e-06	5.4e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—APOE—multiple sclerosis	2.73e-06	5.25e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—POMC—multiple sclerosis	2.35e-06	4.51e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IL6—multiple sclerosis	2.19e-06	4.22e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IL6—multiple sclerosis	2.16e-06	4.15e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ALB—multiple sclerosis	2.14e-06	4.11e-05	CbGpPWpGaD
